exelixis news
Your Search Returned 72 tagged news reports
ASCO Investment Ideas
Ascó :: Spain | 19 days ago
Credibility
Investment Ideas Watch stocks you care about The single, easiest way to keep track of all the stocks that matter.....The American Society of Clinical Oncology annual meeting kicks off today. The scientific conference is the premier place for oncology
Tags:
Here's What This $9 Billion Contrarian Has Been Buying
Alexandria :: VA :: USA | 1 month ago
Credibility
Every quarter, many money managers have to disclose what they've bought and sold, via "13F" filings. Their latest moves can shine a bright light on smart stock picks. Today let's look at Tocqueville Asset Management, a portfolio manager with a
Tags:
5 Stocks Begging for a Short Squeeze
Mexico City :: Mexico | 2 months ago
Credibility
Feeding the bears Higher One was a promising trailblazer a few years ago, offering colleges and their coeds a cost-efficient way to manage financial aid and refunds. There have been a few hiccups along the way, and now growth has slowed dramatically.
Tags:
5 Can't-Miss Health-Care Events This Week
New York City :: NY :: USA | 4 months ago
Credibility
Can't-Miss Health-Care Events This Week Don't let it get away!...Earnings are once again going to steal the spotlight this week, with four of the five can't-miss stories in the health-care sector revolving around earnings reports. There is, however,
Tags:
Exelixis execs win bonuses pay boosts as first cancer drug hits market
South San Francisco :: CA :: USA | 4 months ago
Credibility
Exelixis execs win bonuses, pay boosts as first cancer drug hits market Exelixis President and CEO Michael Morrissey, who will make $700,000 this year, received a 2012 bonus of $373,786. Exelixis Inc.'s top five executives will collect more than $1.1
Tags:
What's Ahead for Exelixis?
Bristol :: VA :: USA | 5 months ago
Credibility
But Cometriq's approval for the niche market of medullary thyroid cancer, or MTC, won't deliver blockbuster revenues, so the company continues to seek more profitable indications...Label expansion Exelixis rode investor confidence all the way to
Tags:
Exelixis makes Cometriq available in US
London :: United Kingdom | 5 months ago
Credibility
S Exelixis has announced the availability of Cometriq (cabozantinib), indicated for medullary thyroid cancer (MTC), in the US. Diplomat Specialty Pharmacy is distributing the product across the US...The receptor tyrosine kinases play a vital role in
Tags:
Here's a Basket of Potentially Explosive Growth
Alexandria :: VA :: USA | 5 months ago
Credibility
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you...Instead of trying to figure out which companies will perform best , you can use this ETF to invest in lots of them simultaneously. The basics ETFs often
Tags:
5 Superball Stocks
Port Moresby :: Papua New Guinea | 7 months ago
Credibility
Companies are selected by screening on finviz.com for abrupt 5% or greater price drops last week...Five super falls -- one superball With the S&P 500 up a modest 0.5% through Friday, you might think last week was a pretty good one for investors.
Tags:
Health-care Stocks: HMA's pre-emptive strike against ‘60 Minutes'
Los Angeles :: CA :: USA | 7 months ago
Credibility
A pre-emptive strike from Health Management Associates directed at an upcoming segment on CBS News' 60 Minutes program didn't keep the company's shares from losing ground Friday. HMA shares were off 3% to $7.83 in recent activity after the company
Tags:
